Arijita Deb
West Virginia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arijita Deb.
Expert Review of Pharmacoeconomics & Outcomes Research | 2015
Usha Sambamoorthi; Xi Tan; Arijita Deb
The prevalence of multiple chronic conditions (MCC) is increasing among individuals of all ages. MCC are associated with poor health outcomes. The presence of MCC has profound healthcare utilization and cost implications for public and private insurance payers, individuals, and families. Investigators have used a variety of definitions for MCC to evaluate costs associated with MCC. The objective of this article is to examine the current literature in estimating excess costs associated with MCC among adults. The discussion highlights some of the theoretical and technical merits of various MCC definitions and models used to estimate the excess costs associated with MCC.
Expert Review of Pharmacoeconomics & Outcomes Research | 2017
Arijita Deb; James Douglas Thornton; Usha Sambamoorthi; Kim E. Innes
ABSTRACT Introduction: Care of individuals with Alzheimer’s Disease and Related Dementias (ADRD) poses special challenges. As the disease progresses, individuals with ADRD require increasing levels of medical care, caregiver support, and long-term care which can lead to substantial economic burden. Areas covered: In this expert review, we synthesized findings from studies of costs of ADRD in the United States that were published between January 2006 and February 2017, highlighted major sources of variation in costs, identified knowledge gaps and briefly outlined directions for future research and implications for policy and program planning. Expert commentary: A consistent finding of all studies comparing individuals with and without ADRD is that the average medical, non-medical, and indirect costs of individuals with ADRD are higher than those without ADRD, despite the differences in the methods of identifying ADRD, duration of the study, payer type and settings of study population. The economic burden of ADRD may be underestimated because many components such as direct non-medical costs for home safety modifications and adult day care services and indirect costs due to the adverse impact of ADRD on caregivers’ health and productivity are not included in cost estimates.
Aging & Mental Health | 2018
Arijita Deb; Usha Sambamoorthi; James Douglas Thornton; Bernard G. Schreurs; Kim E. Innes
ABSTRACT Objective: To estimate the excess direct annual healthcare expenditures associated with Alzheimers and related dementias(ADRD) among community-dwelling older adults in the United States. Methods: This retrospective cross-sectional study compared the annual healthcare expenditures between elderly individuals aged 65 years and older with ADRD (n = 662) and without ADRD (n = 13,398) using data from the Medical Expenditure Panel Survey (MEPS) for the years 2007, 2009, 2011 and 2013. Adjusted total annual medical expenditures was estimated using generalized linear model with gamma distribution and log link in 2013 U.S. dollars. Adjusted inpatient, outpatient, emergency, home healthcare and prescription drug expenditures, were estimated using two-part logit-generalized linear regression models. Results: The adjusted mean total healthcare expenditures were higher for the ADRD group as compared to the no ADRD group(
Current Medical Research and Opinion | 2017
Usha Sambamoorthi; Rahul Garg; Arijita Deb; Tao Fan; Anders Boss
14,508 vs.
Pain Research and Treatment | 2016
Monira Alwhaibi; Arijita Deb; Usha Sambamoorthi
10,096). Among those with ADRD, 34.3% of the expenditures were for home healthcare as compared to 4.4% among those without ADRD. Among users, the ADRD group had significantly higher home healthcare (
Experimental Diabetes Research | 2016
Usha Sambamoorthi; Arijita Deb; Steve Zhou; Rahul Garg; Tao Fan; Anders Boss
3,240 vs.
Arthritis | 2018
Arijita Deb; Nilanjana Dwibedi; Traci LeMasters; Jo Ann Allen Hornsby; Wenhui Wei; Usha Sambamoorthi
566) and prescription drug expenditures(
Current Medical Research and Opinion | 2017
Arijita Deb; Usha Sambamoorthi
3,471 vs.
Value in Health | 2018
Arijita Deb; Nilanjana Dwibedi; Traci LeMasters; Jo Ann Allen Hornsby; Wenhui Wei; Usha Sambamoorthi
2,471). There were no statistically significant differences in inpatient, emergency room and outpatient expenditures between the ADRD and no ADRD group. Conclusion: ADRD in U.S. community-dwelling elders is associated with significant financial burden, primarily driven by increased home healthcare use.
Maternal and Child Health Journal | 2017
J. Douglas Thornton; Arijita Deb; Pamela J. Murray; Kimberly M. Kelly
Abstract Objective: To examine the persistence with rapid-acting insulin (RAI) and its association with clinical outcomes among elderly patients with type 2 diabetes (T2D). Methods: This observational, retrospective cohort study analyzed RAI persistence and its association with change in glycated hemoglobin A1c and risk of severe hypoglycemia among elderly (≥65 years) Medicare beneficiaries with T2D who added RAI to their basal insulin regimen. Results: Among T2D patients with >1 RAI prescriptions (n = 3927), only 21% were persistent. Baseline factors positively associated with RAI persistence (adjusted odds ratio [95% CI]) were: age ≥75 vs. 65–74 years: 1.20 (1.01–1.43); use of ≥3 oral antidiabetes drugs: 1.63 (1.16–2.28); cognitive impairment: 1.34 (1.03–1.73); and A1C >9.0%: 1.58 (1.15–2.17). Elderly T2D patients having emergency department visits (0.73 [0.59–0.91]) and higher RAI out-of-pocket costs (≥